Logo

JBS

JBS N.V.

JBS

JBS N.V. • NYSE
$14.69 ▼ -0.20% (-0.03)
Market Cap $32.58 B
52w High $17.80
52w Low $12.37
Dividend Yield 0.67%
P/E 14.26
Volume 2.07M
Outstanding Shares 2.22B

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $22.597B ▼ $1.753B ▼ $580.887M ▼ 2.571% ▲ $0.52 ▼ $2.149B ▼
Q2-2025 $118.974B ▲ $9.783B ▼ $3.036B ▲ 2.552% ▼ $1.37 ▲ $7.784B ▼
Q1-2025 $114.127B ▼ $10.179B ▼ $2.924B ▲ 2.562% ▲ $1.32 ▼ $9.612B ▲
Q4-2024 $116.701B ▲ $11.745B ▲ $2.412B ▼ 2.067% ▼ $10.36 ▲ $9.373B ▼
Q3-2024 $110.498B $9.569B $3.843B 3.477% $1.73 $13.418B

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $3.558B ▼ $44.186B ▼ $34.677B ▼ $8.717B ▼
Q2-2025 $13.67B ▼ $228.122B ▼ $177.733B ▼ $45.88B ▲
Q1-2025 $27.712B ▼ $239.482B ▼ $192.074B ▼ $43.308B ▼
Q4-2024 $34.762B ▲ $251.936B ▲ $201.566B ▲ $44.781B ▼
Q3-2024 $27.622B $226.576B $174.926B $46.709B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $587.234M ▼ $1.059B ▼ $-584.135M ▲ $680.599M ▲ $1.051B ▲ $542.787M ▲
Q2-2025 $3.036B ▲ $2.936B ▲ $-3.482B ▼ $-13.031B ▼ $-14.041B ▼ $389.592M ▲
Q1-2025 $2.924B ▲ $-3.241B ▼ $-1.423B ▲ $-204.284M ▲ $-7.05B ▼ $-4.788B ▼
Q4-2024 $2.412B ▲ $8.997B ▲ $-2.875B ▼ $-1.876B ▼ $7.139B ▲ $5.902B ▲
Q3-2024 $692.901M $1.343B $-276.921M $387.666M $-7.709K $1.059B

Five-Year Company Overview

Income Statement

Income Statement Revenue has grown strongly over the past five years, with 2024 standing out as a very strong rebound after a tougher 2023. Profitability is clearly cyclical: margins were very healthy in 2021 and 2022, dropped sharply in 2023 with a small loss, then recovered well in 2024 as costs and pricing moved back in JBS’s favor. This pattern is typical of a large protein producer, where livestock costs, export dynamics, and retail pricing can swing results from one year to the next. Overall, the company has shown it can return to solid profits after weaker periods, but earnings are not smooth and can be volatile.

Balance Sheet

Balance Sheet The balance sheet shows a business that has grown in size but carries a heavy debt load. Total assets have expanded steadily, and cash on hand improved in the most recent year, giving the company more day‑to‑day flexibility than before. However, debt has also climbed meaningfully over time, while equity has only edged up, which points to a highly leveraged capital structure. This leverage can amplify returns in good years but leaves the company more exposed during downturns or periods of higher interest rates. The balance sheet is workable for a large, established player, but it does not leave huge room for error.

Cash Flow

Cash Flow JBS consistently generates positive cash flow from its operations, which is a key strength. Even in weaker profit years, the core business brought in cash, although the amounts varied. Free cash flow has been positive but uneven, reflecting both swings in working capital and steady investment in plants, equipment, and technology. Capital spending has been significant and persistent, showing a clear willingness to reinvest in the business. Overall, the company appears able to fund its investments from internal cash generation most of the time, but the combination of high debt and cyclical cash flows means liquidity still needs careful management.

Competitive Edge

Competitive Edge JBS has a powerful competitive position built on sheer size, global reach, and tight control over its supply chain. Its scale in beef, pork, and poultry gives it cost advantages and strong bargaining power with suppliers and customers. Vertical integration—from livestock sourcing through processing and distribution—supports quality, efficiency, and responsiveness to market shifts. The company’s broad geographic footprint and long list of brands help spread risk across countries, products, and channels, including direct‑to‑consumer formats like Swift stores. On the other hand, JBS operates in a tough, commoditized, and highly regulated industry, facing ongoing pressures from competitors, retailers, animal‑health issues, trade policies, and environmental and social scrutiny.

Innovation and R&D

Innovation and R&D Innovation is a clear pillar of JBS’s strategy, and it goes well beyond basic meat processing. The company invests in digital tools—such as data analytics, automation, and AI—to improve efficiency and decision‑making, anchored by its Center of Innovation & Technology. It has also built capabilities in food safety and traceability, and it experiments with new materials like traceable “Kind Leather.” On the product side, JBS is active in plant‑based foods and premium, value‑added meat products, as well as a circular‑economy approach that monetizes byproducts. Most notably, it is moving early into cultivated meat and expanding plant‑based platforms in Europe and Brazil. These initiatives could open new growth avenues, but they remain emerging bets with technological, regulatory, and consumer‑adoption uncertainties.

Summary

JBS combines the strengths of a global protein giant—scale, integration, brand depth, and consistent operating cash flow—with the vulnerabilities of a cyclical, capital‑intensive, and highly leveraged business. Recent results show how quickly profitability can swing, but also how strongly it can recover when conditions improve. The company is not standing still: it is investing heavily in technology, sustainability, and new protein formats, which may help it adapt as consumer preferences evolve and environmental expectations rise. The key ongoing tension is between growth and innovation on one side, and high leverage, industry volatility, and regulatory and ESG risks on the other. How well JBS balances these forces will shape the quality and stability of its future financial performance.

NEWS

November 14, 2025 · 10:28 PM UTC

Mantiqueira USA Announces Acquisition of Hickman's Egg Ranch, Marking U.S. Expansion

Read more